Literature DB >> 7515978

Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts.

A Tosaki1, G A Cordis, P Szerdahelyi, R M Engelman, D K Das.   

Abstract

The effects of preconditioning on development of reperfusion-induced ventricular fibrillation (VF), ventricular tachycardia (VT), free radical formation, and ion shifts, particularly those of Na, K, Ca, and Mg, were studied in isolated rat heart. Hearts were randomly divided into four groups: group I, aerobically perfused time-matched controls with no preconditioning or ischemia; group II, hearts subjected to 30-min global ischemia followed by 30-min reperfusion; group III, hearts subjected to one cycle of preconditioning, consisting of 5-min global ischemia plus 10-min reperfusion, followed by 30-min global ischemia plus 30-min reperfusion; and group IV, hearts subjected to four cycles of preconditioning (5-min ischemia plus 10-min reperfusion) followed by 30-min ischemia plus 30-min reperfusion. The incidences of VF and VT were reduced from their nonpreconditioned ischemic values of 100 and 100% in group II to 83 and 92% in group III and to 33% (p < 0.05) and 41% (p < 0.05) in group IV, respectively. Maximum malondialdehyde formation, as an indirect marker of free radicals, was observed after 30-min ischemia followed by 10-min reperfusion (0.72 +/- 0.1 nmol/ml) in the nonpreconditioned ischemic group (protocol II). One and four cycles of preconditioning reduced formation of malondialdehyde from the nonpreconditioned ischemic value of 0.72 +/- 0.1 to 0.35 +/- 0.02 and 0.26 +/- 0.02 nmol/ml (p < 0.05), respectively. The same trend was observed when free radical formation was directly detected by salicylic acid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515978

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

1.  Donors of nitric oxide mimic effects of ischaemic preconditioning on reperfusion induced arrhythmias in isolated rat heart.

Authors:  M Bilińska; M Maczewski; A Beresewicz
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Reactive oxygen species function as second messenger during ischemic preconditioning of heart.

Authors:  D K Das; N Maulik; M Sato; P S Ray
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

3.  Influence of extracellular potassium on the antiarrhythmic effect of global preconditioning in isolated perfused rat hearts.

Authors:  J Feng; R Chahine; R Nadeau
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

Review 4.  Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning.

Authors:  Péter Ferdinandy; Richard Schulz
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

Review 5.  Ischaemic preconditioning and outcomes after angioplasty: effects of drug therapy.

Authors:  Toru Kato; Nobuo Yoshimoto
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion.

Authors:  N Maulik; T Yoshida; R M Engelman; D Deaton; J E Flack; J A Rousou; D K Das
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

7.  Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts.

Authors:  A Beresewicz; E Czarnowska; M Maczewski
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

8.  Oxidative stress adaptation improves postischemic ventricular recovery.

Authors:  N Maulik; M Watanabe; D T Engelman; R M Engelman; D K Das
Journal:  Mol Cell Biochem       Date:  1995-03-09       Impact factor: 3.396

9.  Peroxynitrite: in vivo cardioprotectant or arrhythmogen?

Authors:  P Eaton; H Clements-Jewery
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.